Status:
UNKNOWN
Atypical Orofacial Pain Diagnostics and Differentiation.
Lead Sponsor:
Lithuanian University of Health Sciences
Conditions:
Persistent Idiopathic Facial Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Orofacial pain is diagnosed for more than 1.9 percent of general population and for 0.3 percent origin of the facial pain is unknown. Commonly atypical facial pain is treated as a neurological conditi...
Eligibility Criteria
Inclusion
- Experimental group The experimental group will consist only of adult patients (18-70years old), who were clinically diagnosed with atypical pain syndrome (G50.1) after all diagnostic measures were performed.
- Inclusion criteria:
- Adult patients (18-70years old) who were clinically diagnosed with atypical pain syndrome (G50.1).
- Patients who accepted terms of this research and has signed informed consent form.
- Patients were not previously diagnosed with a psychiatric disorder.
- Exclusion criteria:
- A potential participant of the study is not able to comprehend information regarding this study's protocol in both written and verbal forms or fails/refuses to sign an informed consent form.
- Patients who have a diagnosed organic pathology causing orofacial pain.
- Patients who are diagnosed with systemic diseases which may interfere with the study or patients who present with head or neck oncology pathologies.
- Patients who were previously diagnosed with a psychiatric disorder.
- Control group Control group will consist of patients who were subjected to maxillofacial fracture (any jaw unilateral fracture). These patients will be involved in this study if they are hospitalized/or have visited Lithuanian University of Health Sciences hospital Kaunas Clinics Department of maxillofacial surgery.
- Inclusion criteria:
- Adult patients (18-70year old) who have been diagnosed with orofacial pain due to jaw fracture (S02.3, S02.4, S02.6).
- Patients who have signed an informed consent form.
- Patients who were not previously diagnosed with a psychiatric disorder.
- Exclusion criteria:
- A potential participant of the study is not able to comprehend information regarding this study's protocol in both written and verbal forms or fails/refuses to sign an informed consent form.
- Patients who are diagnosed with systemic diseases which may interfere with the study or patients who present with head or neck oncology pathologies.
- Patients who were previously diagnosed with a psychiatric disorder.
Exclusion
Key Trial Info
Start Date :
February 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04775758
Start Date
February 27 2021
End Date
August 1 2021
Last Update
March 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lithuanian University of Health Sciences Kaunas Clinics
Kaunas, Lithuania